Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
tech and healthcare strength, and the Dow Jones Industrial Average (DJINDEX: ^DJI) edged up 0.16% to 48,442.41 in quiet holiday trading. Obesity-drug leader Novo Nordisk (NYSE:NVO) advanced on FDA approval of its Wegovy pill, lifting healthcare sentiment, while software giant ServiceNow (NYSE:NOW) slid nearly 3% after unveiling a $7.75 billion deal for cybersecurity firm Armis, pressuring large-cap software within the Nasdaq. Economic momentum remained firm, with third-quarter GDP growth of 4.3% supporting risk appetite as markets held near record levels. For investors, the takeaway is less about short-term momentum and more about policy expectations, as resilient growth gives the Federal Reserve room to remain patient on rate cuts while forecasts extend into 2026. Mega-cap technology and AI stocks remain the primary drivers of index performance, a dynamic that can lift indexes while masking thinner participation. Healthcare strength following Novo Nordisk's Wegovy pill approval
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Lilly, Novo lock horns in India's obesity drug race [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk gets landmark obesity pill approved, with production ‘underway' in NC [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk says FDA approved Wegovy pill to reduce body weight [Yahoo! Finance]Yahoo! Finance
- Launch of Wegovy pill is core to Novo Nordisk's growth, says Guggenheim's Seamus Fernandez [CNBC]CNBC
- Why Novo Nordisk Stock Popped Today [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website